Want to see IN:AAREYDRUGS full AI Analyst Report?
Total Valuation
Aarey Drugs & Pharmaceuticals Ltd. has a market cap or net worth of ₹2.86B. The enterprise value is ₹1.91K.
Market Cap₹2.86B
Enterprise Value₹1.91K
Share Statistics
Aarey Drugs & Pharmaceuticals Ltd. has 28,354,303 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding28,354,303
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Aarey Drugs & Pharmaceuticals Ltd.’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is 1.57%.
Return on Equity (ROE)0.03
Return on Assets (ROA)0.01
Return on Invested Capital (ROIC)1.57%
Return on Capital Employed (ROCE)0.03
Revenue Per Employee35.78M
Profits Per Employee300.58K
Employee Count132
Asset Turnover1.59
Inventory Turnover11.03
Valuation Ratios
The current PE Ratio of Aarey Drugs & Pharmaceuticals Ltd. is 69.2. Aarey Drugs & Pharmaceuticals Ltd.’s PEG ratio is -13.05.
PE Ratio69.2
PS Ratio0.31
PB Ratio0.96
Price to Fair Value0.96
Price to FCF-6.19
Price to Operating Cash Flow19.81
PEG Ratio-13.05
Income Statement
In the last 12 months, Aarey Drugs & Pharmaceuticals Ltd. had revenue of 4.72B and earned 39.68M in profits. Earnings per share was 1.39.
Revenue4.72B
Gross Profit141.50M
Operating Income43.19M
Pretax Income54.14M
Net Income39.68M
EBITDA132.69M
Earnings Per Share (EPS)1.39
Cash Flow
In the last 12 months, operating cash flow was 145.98M and capital expenditures -100.49M, giving a free cash flow of 45.49M billion.
Operating Cash Flow145.98M
Free Cash Flow45.49M
Free Cash Flow per Share1.60
Dividends & Yields
Aarey Drugs & Pharmaceuticals Ltd. pays an annual dividend of ₹0.1, resulting in a dividend yield of 0.23%
Dividend Per Share₹0.1
Dividend Yield0.23%
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.42
52-Week Price Change35.73%
50-Day Moving Average84.99
200-Day Moving Average77.58
Relative Strength Index (RSI)68.92
Average Volume (3m)13.54K
Important Dates
Aarey Drugs & Pharmaceuticals Ltd. upcoming earnings date is Nov 12, 2026, TBA (Confirmed).
Last Earnings DateAug 14, 2026
Next Earnings DateNov 12, 2026
Ex-Dividend Date―
Financial Position
Aarey Drugs & Pharmaceuticals Ltd. as a current ratio of 1.81, with Debt / Equity ratio of 0.00%
Current Ratio1.81
Quick Ratio1.53
Debt to Market Cap0.34
Net Debt to EBITDA3.66
Interest Coverage Ratio0.86
Taxes
In the past 12 months, Aarey Drugs & Pharmaceuticals Ltd. has paid 14.47M in taxes.
Income Tax14.47M
Effective Tax Rate0.27
Enterprise Valuation
Aarey Drugs & Pharmaceuticals Ltd. EV to EBITDA ratio is 14.58, with an EV/FCF ratio of -8.27.
EV to Sales0.41
EV to EBITDA14.58
EV to Free Cash Flow-8.27
EV to Operating Cash Flow-17.61
Balance Sheet
Aarey Drugs & Pharmaceuticals Ltd. has ₹33.98M in cash and marketable securities with ₹0.00 in debt, giving a net cash position of ₹33.98M billion.
Cash & Marketable Securities₹33.98M
Total Debt₹0.00
Net Cash₹33.98M
Net Cash Per Share₹1.20
Tangible Book Value Per Share₹52.70
Margins
Gross margin is 2.86%, with operating margin of 0.91%, and net profit margin of 0.84%.
Gross Margin2.86%
Operating Margin0.91%
Pretax Margin1.15%
Net Profit Margin0.84%
EBITDA Margin2.81%
EBIT Margin2.21%
Analyst Forecast
The average price target for Aarey Drugs & Pharmaceuticals Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-7.69%
EPS Growth Forecast-0.35%